DrugPatentWatch Database Preview
Patent: 10,258,619
Try a free trial
See Plans and Pricing
Summary for Patent: 10,258,619
| Title: | Combination therapy with glutaminase inhibitors and immuno-oncology agents |
| Abstract: | The invention relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases with a combination of a glutaminase inhibitor and an immuno-oncology therapeutic agent, such as an inhibitor of arginase, CTLA-4, indoleamine 2,3-dioxygenase, and/or PD-1/PD-L1. |
| Inventor(s): | Molineaux; Susan M. (San Francisco, CA), Gross; Matthew I. (San Francisco, CA), Bromley; Susan D. (San Francisco, CA), Parlati; Francesco (San Francisco, CA), Bennett; Mark K. (Moraga, CA) |
| Assignee: | Calithera Biosciences, Inc. (South San Francisco, CA) |
| Application Number: | 15/284,865 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,258,619
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca Uk Ltd | IMFINZI | durvalumab | INJECTABLE;INJECTION | 761069 | 001 | 2017-05-01 | ➤ Sign Up | Calithera Biosciences, Inc. (South San Francisco, CA) | 2035-10-05 | RX | search | |
| Amgen | BLINCYTO | blinatumomab | INJECTABLE;INJECTION | 125557 | 001 | 2014-12-03 | ➤ Sign Up | Calithera Biosciences, Inc. (South San Francisco, CA) | 2035-10-05 | RX | Orphan | search |
| Bristol Myers Squibb | OPDIVO | nivolumab | INJECTABLE;INJECTION | 125554 | 001 | 2015-11-23 | ➤ Sign Up | Calithera Biosciences, Inc. (South San Francisco, CA) | 2035-10-05 | RX | Orphan | search |
| Bristol Myers Squibb | OPDIVO | nivolumab | INJECTABLE;INJECTION | 125527 | 002 | 2015-03-04 | ➤ Sign Up | Calithera Biosciences, Inc. (South San Francisco, CA) | 2035-10-05 | RX | search | |
| Bristol Myers Squibb | OPDIVO | nivolumab | INJECTABLE;INJECTION | 125527 | 001 | 2015-03-04 | ➤ Sign Up | Calithera Biosciences, Inc. (South San Francisco, CA) | 2035-10-05 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
